Bank Of America Corp Annexon, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 167,160 shares of ANNX stock, worth $884,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,160

Previous 65,560 154.97%

Holding current value

$884,276

Previous $321,000 208.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.49 - $7.2 $456,184 - $731,520	101,600 Added 154.97%	167,160 $989,000
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $44,711 - $70,113	-10,326 Reduced 13.61%	65,560 $321,000
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $98,984 - $191,829	24,562 Added 47.86%	75,886 $544,000
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $6,880 - $19,543	4,221 Added 8.96%	51,324 $233,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $7,056 - $21,403	3,360 Added 7.68%	47,103 $165,000
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $130,170 - $259,645	34,805 Added 389.4%	43,743 $168,000
Q4 2022 Feb 10, 2023	BUY	$4.56 - $6.61 $9,343 - $13,543	2,049 Added 29.74%	8,938 $46,000
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $5,958 - $10,535	-1,589 Reduced 18.74%	6,889 $43,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $95,182 - $183,146	-45,110 Reduced 84.18%	8,478 $31,000
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $116,732 - $510,542	-42,759 Reduced 44.38%	53,588 $146,000
Q4 2021 Feb 08, 2022	BUY	$11.49 - $22.0 $995,217 - $1.91 Million	86,616 Added 890.1%	96,347 $1.11 Million
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $16,954 - $24,265	-1,037 Reduced 9.63%	9,731 $181,000
Q2 2021 Sep 13, 2021	BUY	$17.81 - $27.48 $191,778 - $295,904	10,768 New	10,768 $243,000

Others Institutions Holding ANNX

# of Institutions

146

Shares Held

102M

Call Options Held

178K

Put Options Held

159K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $252M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Annexon, Inc. Transaction History